Superantigen-induced corticosteroid resistance of human T cells occurs through activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase (MEK-ERK) pathway.

[1]  P. Rothman,et al.  Enhancement of MEK/ERK signaling promotes glucocorticoid resistance in CD4+ T cells , 2004 .

[2]  G. Haegeman,et al.  The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repression. , 2003, Endocrine reviews.

[3]  H. Schneider,et al.  Unifying concepts in CD28, ICOS and CTLA4 co-receptor signalling , 2003, Nature Reviews Immunology.

[4]  Claus Bachert,et al.  IgE to Staphylococcus aureus enterotoxins in serum is related to severity of asthma. , 2003, The Journal of allergy and clinical immunology.

[5]  J. Bloom,et al.  Update on glucocorticoid action and resistance. , 2003, The Journal of allergy and clinical immunology.

[6]  K. Kisich,et al.  A Role for STAT5 in the Pathogenesis of IL-2-Induced Glucocorticoid Resistance1 , 2002, The Journal of Immunology.

[7]  K. Imai,et al.  Nuclear export of glucocorticoid receptor is enhanced by c-Jun N-terminal kinase-mediated phosphorylation. , 2002, Molecular endocrinology.

[8]  D. Zaller,et al.  Staging and resetting T cell activation in SMACs , 2002, Nature Immunology.

[9]  M. Garabedian,et al.  Deciphering the Phosphorylation “Code” of the Glucocorticoid Receptor in Vivo * 210 , 2002, The Journal of Biological Chemistry.

[10]  B. Myones,et al.  Prevalence of superantigen-secreting bacteria in patients with Kawasaki disease. , 2002, The Journal of pediatrics.

[11]  I. Adcock,et al.  p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. , 2002, The Journal of allergy and clinical immunology.

[12]  D. Olive,et al.  Differential effect of CD28 versus B7 blockade on direct pathway of allorecognition and self-restricted responses. , 2002, Blood.

[13]  A. Chow,et al.  Temporal sequence and functional implications of V beta-specific T cell receptor down-regulation and costimulatory molecule expression following in vitro stimulation with the staphylococcal superantigen Toxic shock syndrome toxin-1. , 2002, The Journal of infectious diseases.

[14]  Søren Buus,et al.  Role of the T Cell Receptor Ligand Affinity in T Cell Activation by Bacterial Superantigens* , 2001, The Journal of Biological Chemistry.

[15]  J. Gutiérrez-Ramos,et al.  Cutting Edge: The Related Molecules CD28 and Inducible Costimulator Deliver Both Unique and Complementary Signals Required for Optimal T Cell Activation , 2001, The Journal of Immunology.

[16]  K. Yamamoto,et al.  Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  G. Chrousos,et al.  Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens. , 2000, The Journal of allergy and clinical immunology.

[18]  S. Wenzel,et al.  Increased T-cell receptor vbeta8+ T cells in bronchoalveolar lavage fluid of subjects with poorly controlled asthma: a potential role for microbial superantigens. , 1999, The Journal of allergy and clinical immunology.

[19]  L. Picker,et al.  Evidence for superantigen involvement in skin homing of T cells in atopic dermatitis. , 1999, The Journal of investigative dermatology.

[20]  Michael Loran Dustin,et al.  Costimulation: Building an Immunological Synapse , 1999, Science.

[21]  Colin R. F. Monks,et al.  Three-dimensional segregation of supramolecular activation clusters in T cells , 1998, Nature.

[22]  J. Cidlowski,et al.  Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence 1 1 Proceedings of the 13th International Symposium of the Journal of Steroid Biochemistry & Molecular Biology “Recent Advances in Steroid Biochemistry & Molecular Biology” Monaco 25–28 May 1997. , 1998, The Journal of Steroid Biochemistry and Molecular Biology.

[23]  S. Logan,et al.  Antagonism of glucocorticoid receptor transcriptional activation by the c-Jun N-terminal kinase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Mitogen-activated and cyclin-dependent protein kinases selectively and differentially modulate transcriptional enhancement by the glucocorticoid receptor , 1997, Molecular and cellular biology.

[25]  J. Cidlowski,et al.  Mouse Glucocorticoid Receptor Phosphorylation Status Influences Multiple Functions of the Receptor Protein* , 1997, The Journal of Biological Chemistry.

[26]  M. Berridge.  Lymphocyte activation in health and disease. , 1997, Critical reviews in immunology.

[27]  H. Jabara,et al.  The superantigen toxic shock syndrome toxin-1 induces CD40 ligand expression and modulates IgE isotype switching. , 1996, International immunology.

[28]  K. Durongpisitkul,et al.  The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. , 1995, Pediatrics.

[29]  J. Travers,et al.  Evidence for a streptococcal superantigen-driven process in acute guttate psoriasis. , 1995, The Journal of clinical investigation.

[30]  J. Allison,et al.  CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation , 1995, The Journal of experimental medicine.

[31]  M. Moser,et al.  Activation of murine T cells by bacterial superantigens requires B7-mediated costimulation. , 1995, Cellular immunology.

[32]  P. R. Housley,et al.  Site-directed mutagenesis of the phosphorylation sites in the mouse glucocorticoid receptor. , 1993, The Journal of biological chemistry.

[33]  S. Walker,et al.  Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. , 1993, The Journal of clinical investigation.

[34]  P. Marrack,et al.  Superantigens and their potential role in human disease. , 1993, Advances in immunology.

[35]  J. Allison,et al.  CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones , 1992, Nature.

[36]  P. Marrack,et al.  Evidence for the effects of a superantigen in rheumatoid arthritis. , 1991, Science.

[37]  M. Merćep,et al.  Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. , 1990, Journal of immunology.

[38]  P. Schlievert,et al.  Clindamycin-induced suppression of toxic-shock syndrome--associated exotoxin production. , 1984, The Journal of infectious diseases.

[39]  J. Leyden,et al.  The case for steroid—antibiotic combinations , 1977, The British journal of dermatology.

[40]  H. Maibach,et al.  Co‐operative double‐blind trial of an antibiotic/ corticoid combination in impetiginized atopic dermatitis , 1976, The British journal of dermatology.